Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing bimatoprost (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bimatoprost (substance) |
Inferred relationship |
Some |
1 |
Bimatoprost 0.3mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bimatoprost (substance) |
Inferred relationship |
Some |
|
Topical form bimatoprost |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bimatoprost (substance) |
Inferred relationship |
Some |
|
Product containing precisely bimatoprost 300 microgram/1 milliliter conventional release eye drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bimatoprost (substance) |
Inferred relationship |
Some |
|
Product containing bimatoprost and timolol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bimatoprost (substance) |
Inferred relationship |
Some |
1 |
Product containing bimatoprost in ophthalmic dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bimatoprost (substance) |
Inferred relationship |
Some |
|
Product containing precisely bimatoprost 300 microgram/1 milliliter conventional release eye drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Bimatoprost (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely bimatoprost 300 microgram/1 milliliter conventional release eye drops (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Bimatoprost (substance) |
Inferred relationship |
Some |
1 |
Bimatoprost-containing product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bimatoprost (substance) |
Inferred relationship |
Some |
1 |
Bimatoprost and timolol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bimatoprost (substance) |
Inferred relationship |
Some |
1 |
Bimatoprost only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bimatoprost (substance) |
Inferred relationship |
Some |
1 |
Product containing only bimatoprost in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bimatoprost (substance) |
Inferred relationship |
Some |
1 |
Product containing bimatoprost and timolol in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bimatoprost (substance) |
Inferred relationship |
Some |
1 |
Product containing only bimatoprost and timolol in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bimatoprost (substance) |
Inferred relationship |
Some |
1 |
Bimatoprost 300 microgram/mL and timolol (as timolol maleate) 5 mg/mL eye drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Bimatoprost (substance) |
Inferred relationship |
Some |
1 |
Bimatoprost 300 microgram/mL and timolol (as timolol maleate) 5 mg/mL eye drops |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Bimatoprost (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely bimatoprost 100 microgram/1 milliliter conventional release eye drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Bimatoprost (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely bimatoprost 100 microgram/1 milliliter conventional release eye drops (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Bimatoprost (substance) |
Inferred relationship |
Some |
1 |